ExpiresAugust 21, 2022
American Medical Association
Prenatal providers and patients have more options than ever for screening for Down syndrome and other chromosome conditions, including cell-free DNA screening. In this module, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care.
1. This activity is hosted on the AMA Ed Hub.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Allergy and Immunology
Colon and Rectal Surgery
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
1. Determine whether cell-free DNA screening is appropriate for the patient
2. Interpret results of cell-free DNA screening in the context of the patient characteristics
Genetics and Genomics, Pathology and Laboratory Medicine
Patient Care & Procedural Skills, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit